Supplementary Methods

Primary CD4
+ T cell isolation and treatments All patients will receive approximately 30 cc peripheral blood draw on days 0, day 1 or day 2, and day 10 or day 22 after Picato application. Blood was drawn into EDTA tubes by the physicians or personnel who were certified in phlebotomy and processed within two hours. After blood collection, PBMCs were isolated using Ficoll as described before. Some of these PBMCs were run for flow cytometry to measure immune activation. The reminders of the PBMCs were further processed to purify primary CD4 + T cells with negative isolation using EasySep kit from STEMCELL Technologies Inc. (Vancouver, BC, Canada) 7, 8 . The purified CD4 + T cells were immediately frozen in the liquid nitrogen for RNA/DNA extraction further.
Immune activation/flow assays Peripheral blood mononuclear cells (PBMCs) were stained using standard methods in a panel containing anti-CD3-PacificBlue (PacBlue) (antibodies from BD Biosciences), anti-CD25-PE-Cy7, anti-CD38-PE, anti-CCR5-APC, anti-CD69-APC-H7, anti-CD8-PerCP-Cy5. minutes. Then, the plate was washed as above and streptavidin-PE was added. After incubation for 10 minutes at room temperature and washes as above, the assay buffer was added to the wells. Each sample was measured in triplicates. Plates were read using a Luminex 200 instrument (Bio-rad) with a lower bound of 50 beads per sample per cytokine.
The cytokine concentration was determined by a Bio-Plex ManagerTM software (Bio-rad) based on standard curves for each cytokine.
Suppl. Table 1 . Patients participated in this study.
Suppl. Table 2 . Basal levels of HIV RNA in the primary CD4 + T cells and in the skin biopsies in the patients without ingenol mebutate application (n=5).
Suppl. Table 3 
